(Photo from ABC News)

On Monday, Johnson & Johnson announced that it was pausing COVID-19 vaccine clinical trials due to an unexplained illness in a study participant. Eli Lilly and Company also stopped its Covid vaccine trials because of potential safety concern, as voiced by US government officials. Eli Lilly had been testing the treatment on hospitalized COVID patients, all of whom had received remdesivir.

At the moment, Johnson & Johnson’s patient is being reviewed and evaluated by independent monitoring board and company’s doctors. This comes at the head of AstraZeneca’s pausing its Covid-19 vaccine trials last month to investigate an illness in a patient in the UK. The study has resumed in the UK and other countries but not in the US.

The dean of Brown University School of Public Health, Ashish Jha stated that this was completely expected, but that the political pressure and desire simply was unrealistic to adhere to.

Coree ILBO/CoreeDaily.com copyright (c) 2013-2020, All rights reserved.

This material may not be published, broadcast, rewritten or redistributed in whole or part with out the express written permission.